CompletedPhase 3NCT01246479

Long Term Immunity and Safety Following Vaccination With the JEV IC51 (IXIARO®, JESPECT®) in Pediatric Population In Non Endemic Countries. Uncontrolled, Ph3 FU-Study

Studying Encephalitis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Valneva Austria GmbH
Principal Investigator
Andrea Ayad, Dr.
Valneva Austria GmbH
Intervention
Blood draw(procedure)
Enrollment
23 enrolled
Eligibility
20 years · All sexes
Timeline
2010 – 2014

Study locations (5)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01246479 on ClinicalTrials.gov

Other trials for Encephalitis

Additional recruiting or active studies for the same condition.

See all trials for Encephalitis →

← Back to all trials